EATG » Access

Access

A leading HIV drug is way overpriced in the US

A House hearing over the price of Truvada shows a particularly glaring example of a rampant industry practice. Gilead Sciences Inc. CEO Daniel O'Day has only been on the job…

European Civil Society organisations request for an investigation regarding medicines shortages

The European AIDS Treatment Group and 30 other Civil Society organisations have reached out to the European Commission today to ask for a strong EU engagement to tackle the issue…

Health Policy Watch Makes Latest Text Of WHO Transparency Resolution Open Access

Health Policy Watch is publishing in an open-access format the latest draft of the World Health Assembly resolution on transparency of drug costs. The new draft, now available to all, reflects…

Several developed countries want to “derail” transparency resolution – civil society groups say

More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the…

Mexican official resigns as HIV drug shortage sparks outcry

MEXICO CITY, May 9 - A top Mexican health official said on Thursday that he had resigned amid growing anger over drug shortages that have left hundreds of HIV patients…

Out-of-pocket expenses hamper access to HIV services

User fees and other out-of-pocket expenses―defined as direct payments made by people to health-care providers at the time of service use―are a major barrier to people getting tested for HIV,…

Analytical report: Human rights of women living with HIV in Ukraine

The Eurasian Women's Network on AIDS released an analytical report, Human rights of women living with HIV in Ukraine, based on data collected by HIV-positive women in 10 regions of…

Ensuring access to life-saving medicines as countries shift from Global Fund support

An editorial published in the Bulletin of the World Health Organization explains the risks related to the quality, affordability and supply of HIV and TB medical commodities with the shift from…

Why has the uptake of lopinavir/ritonavir oral pellets for children been slow?

Lopinavir/ritonavir (LPV/r) oral pellets and oral granules for infants and young children living with HIV have proven advantages in terms of efficacy and tolerability over other formulations of LPV/r, but…

Drug price transparency: 10 countries back World Health Assembly resolution

Ten countries, including five European Union (EU) member states, have now lined up in support of a landmark resolution to increase transparency of drug prices globally, which is expected to…